Stockscreener 앱 받기
5.32
4.93%
0.25
시간 외 거래:
5.32
Trisalus Life Sciences Inc 주식(TLSI)의 최신 뉴스
TriSalus Life Sciences (NASDAQ:TLSIW) Stock Price Down 7.1% – Should You Sell? - Defense World
TriSalus shareholders elect directors, ratify auditor By Investing.com - Investing.com South Africa
TriSalus shareholders elect directors, ratify auditor - Investing.com
TriSalus Life Sciences Holds Annual Shareholder Meeting - TipRanks
Equities Analysts Set Expectations for TLSI FY2026 Earnings - Defense World
Cantor Fitzgerald maintains $9 target on TriSalus stock By Investing.com - Investing.com Nigeria
Millennium Management LLC Cuts Holdings in TriSalus Life Sciences, Inc. (NASDAQ:TLSI) - Defense World
Cantor Fitzgerald maintains $9 target on TriSalus stock - Investing.com
Bank of America Corp DE Raises Holdings in TriSalus Life Sciences, Inc. (NASDAQ:TLSI) - Defense World
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
TriSalus Launches TriNav FLX To Enhance Drug Delivery In Complex Peripheral Vessels - Nasdaq
TriSalus Life Sciences Announces the Launch of the TriNav FLX Infusion System - Bluefield Daily Telegraph
TriSalus Unveils Next-Gen Cancer Treatment Device: New TriNav FLX Shows 28% Better Navigation - Stock Titan
Northern Trust Corp Has $161,000 Position in TriSalus Life Sciences, Inc. (NASDAQ:TLSI) - Defense World
Cantor Fitzgerald maintains TriSalus stock rating after CFO change By Investing.com - Investing.com South Africa
Cantor Fitzgerald maintains TriSalus stock rating after CFO change - Investing.com
TriSalus Life Sciences names new CFO - BizWest
TriSalus Life Sciences (TLSI) Plans to Offer 5.5M Shares of Comm - GuruFocus
TriSalus Life Sciences (TLSI) Names New Chief Financial Officer - GuruFocus
TriSalus Life Sciences (TLSI) Plans to Offer 5.5M Shares of Common Stock | TLSI Stock News - GuruFocus
TriSalus Life Sciences Appoints David Patience as CFO - marketscreener.com
TriSalus Life Sciences Appoints David Patience To Succeed James Young As CFO - Nasdaq
TriSalus Names David Patience Finance Chief as James Young Departs - MarketWatch
TriSalus Life Sciences appoints new CFO amid transition - Investing.com
TriSalus Life Sciences, Inc. Announces Chief Financial Officer Changes - marketscreener.com
TriSalus Life Sciences Announces Chief Financial Officer Transition With Appointment of David B. Patience - Business Wire
TriSalus Life Sciences (NASDAQ:TLSIW) Stock Price Up 3.9% – Should You Buy? - Defense World
Roth Capital Issues Negative Estimate for TLSI Earnings - Defense World
TLSI FY2025 EPS Estimate Reduced by Cantor Fitzgerald - Defense World
TriSalus outlines at least 50% revenue growth for 2025 as new Medicare code expands addressable market - MSN
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q1 2025 Earnings Call Transcript - MSN
Analysts Set TriSalus Life Sciences, Inc. (NASDAQ:TLSI) PT at $10.93 - Defense World
Trisalus Life Sciences Q1 2025 Earnings Call Highlights - TipRanks
TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates - MSN
Earnings call transcript: TriSalus Life Sciences projects 50% revenue growth in Q1 2025 - Investing.com Nigeria
TriSalus Life Sciences Reports Strong Q1 2025 Growth - TipRanks
Transcript : TriSalus Life Sciences, Inc., Q1 2025 Earnings Call, May 15, 2025 - marketscreener.com
TriSalus (TLSI) Exceeds Revenue Expectations in Q1 | TLSI Stock News - GuruFocus
Trisalus Life Sciences Q1 Pretax Profit USD -10.37 Million - marketscreener.com
TriSalus Life Sciences, Inc. Updates Earnings Guidance for the Year 2025 - marketscreener.com
TriSalus Life Sciences (TLSI) Projected to Post Quarterly Earnings on Wednesday - Defense World
TriSalus Life Sciences to Host First Quarter 2025 Financial Results Conference Call - Business Wire
13,400 Shares in TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Acquired by Renaissance Technologies LLC - Defense World
Geode Capital Management LLC Purchases 3,710 Shares of TriSalus Life Sciences, Inc. (NASDAQ:TLSI) - Defense World
Northland maintains TriSalus stock with $12.50 target - Investing.com Australia
Northland maintains TriSalus stock with $12.50 target By Investing.com - Investing.com India
TLSI Reports Strong Revenue Growth in First Quarter of 2025 | TL - GuruFocus
TriSalus Life Sciences (TLSI) Secures $22M Investment and Plans Capital Restructuring | TLSI Stock News - GuruFocus
TriSalus Life Sciences secures $22 million in funding By Investing.com - Investing.com India
TriSalus Life Sciences secures $22 million in funding - Investing.com
TriSalus Life Sciences Announces $22.0 Million Private Placement Preliminary Q1 2025 Unaudited Financial Results - Business Wire
TriSalus Life Sciences files to offer up to 3.34M shares - MSN
TriSalus Life Sciences announces board member resignation By Investing.com - Investing.com Canada
TriSalus Life Sciences announces board member resignation - Investing.com Australia
1.05%
0.64%
자본화:
|
볼륨(24시간):